Sponsor pipeline

Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair clinical trial pipeline

Get alerts when Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair's trials change

2 active trials 0 recruiting 2 Phase 3 4 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 2/3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2/3
NCT01064466 Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms Small Cell Lung Cancer Active, Not Recruiting 2026-08-27
NCT07033585 Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With… Type 2 Diabetes Active, Not Recruiting 2026-08-27

Disease areas by active trials

Diabetes (1) · Lung Cancer (1) · Small Cell Lung Cancer (1) · Type 2 Diabetes (1)

Get alerts when Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free